Champions Oncology - End to End Pharmacology Solutions

End to End Pharmacology Solutions
Bridging the Gap Between Research and Clinic

Leverage a range of research and development solutions to improve the productivity of oncology drug development

New Offering: huSyngeneic Screen
Human Transgenic MC38 Syngeneic System

ENROLLMENT OPEN NOW THROUGH NOVEMBER 30TH

2nd European Oncology and Immuno-Oncology Drug Discovery Symposium, Basel
Tuesday October 22, 2019

1st Annual Translational Oncology Symposium, San Francisco
Thursday November 14, 2019

PDX Model Spotlight
EX20 EGFR Mutant Models

AACR 2019 Poster Presentation

AML PDX Platform to Evaluate Novel Therapeutic Agents

Our Latest Webinar

Clinical Flow Cytometry: Validation and Implementation in a Regulatory Setting

On-Demand Webinar Series

Learn more about humanized mouse models for the preclinical evaluation of novel immunotherapies

Access the Champions TumorGraft Database

Identify PDX cohorts based on molecular characteristics, patient treatment, standard-of-care testing outcomes, clinical features and more

Read Our Latest Newsletter

Hematology
Oncology Models

Champions Oncology Partners with TransCure bioServices to Expand European Business and Operations

Champions Oncology Reports Record Quarterly Revenue of $6.2 Million